Arctic Bioscience H1 adjusted EBITDA loss narrows; 2026 growth expected
Arctic Bioscience reports its H1 adjusted EBITDA loss narrowing on a boost from America and expects growth in 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.